42 reports

This has boosted sales of slimming teas and weight loss supplements.

  • Acne Treatment
  • OTC
  • Malaysia
  • Demand
  • GlaxoSmithKline plc

However, weight loss supplements and meal replacement products have not achieved widespread popularity as most people are more willing to try traditional methods and remedies when seeking to lose weight.

  • Acne Treatment
  • Gastrointestinal Drug
  • Tanzania
  • Demand
  • GlaxoSmithKline plc
  • 4.1 ETIOLOGY AND PATHOPHYSIOLOGY

GlobalData epidemiologists calculated the age-standardized one-year total prevalence by multiplying the age-specific one-year total prevalence proportions from each country by the age-specific world standard population weights (Segi, 1960).

  • Opioid
  • Therapy
  • United States
  • Forecast
  • Omeros Corporation

WEIGHT MANAGEMENT AND WELLBEING Prospects Passport ## Competitive Landscape Slimming teas and weight loss supplements are the most popular products.

  • Acne Treatment
  • Gastrointestinal Drug
  • OTC
  • Uganda
  • Demand

Wound care creams and weight loss products are also significant within traditional medicine.

  • Acne Treatment
  • Gastrointestinal Drug
  • OTC
  • Myanmar
  • Demand

Some of the leading brands of weight loss supplements include Holondiet Drenante, which comes in tonic format, Kit Emagreço Já, a brand of weight loss supplements in tablet form, and DietLimão Depur, weight loss supplements in tablet and tonic fo

  • Acne Treatment
  • Gastrointestinal Drug
  • OTC
  • Angola
  • Demand

The weight loss supplements are marketed as calorie burning products.

  • Acne Treatment
  • Gastrointestinal Drug
  • OTC
  • Sri Lanka
  • Demand

Weight loss supplements products have been used for a long time by Jordanians looking to lose weight, with these being the most popular weight management and wellbeing products in the country.

  • Acne Treatment
  • Opioid
  • OTC
  • Jordan
  • Demand

These products are also more affordable than other products, notably weight loss supplements.

  • Acne Treatment
  • OTC
  • Vitamin
  • Iraq
  • Demand

Most often they are drugs for sexual dysfunction, heartburn, weight loss, digestive problems, anxiety or cancer.

  • Acne Treatment
  • OTC
  • Czech Republic
  • Demand

The main new development regarding many sports nutrition stores (both online and regular bricks-and-mortar outlets) was the addition of vegan weight management and wellbeing products such as meal replacement and weight loss supplements to their portfolios.

  • Acne Treatment
  • OTC
  • Austria
  • Demand

Passport ## Forecast Sales of Weight Management and Wellbeing by Category: Value 2019- Source: Euromonitor International from official statistics, trade associations, trade press, company research, store checks, trade interviews, trade sources Table ## 2014-2019 % current value growth Meal

  • Acne Treatment
  • OTC
  • Laos
  • Thailand
  • Demand

(USA) ##.

  • Analgesic
  • Opioid
  • Therapy
  • United States
  • Market Shares

FOR ALL OTHER PARAMETERS, BOTH BATTERY CONTAINING AND BATTERY FREE [Light Therapy = ##]; [Others=##]; [Weight = ##] Score = [## = ##]; [## = ##. ##]; [## = ##]; [## < = ##]; [Weight = ##. ##] Score = [## - ## = ##]; [##-## = ##. ##]; [## - ##= ##.

  • Opioid
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

You can easily book an appointment with one online.

  • Acne Treatment
  • Dermatological Condition
  • Opioid
  • Allergan plc
  • Galderma S.A.
  • NEO-1940 - DRUG PROFILE

The new dronabinol chewing gum product will be bioequivalent to Marinol, and will be used to help treat patients with chemotherapy induced nausea and vomiting and AIDS patients experiencing appetite and weight loss.

  • Chemotherapy
  • Opioid
  • United States
  • Product Initiative
  • Helsinn Group

The net loss of the company was AUD## million in FY2018, compared to a net loss of AUD##. ## million in FY2017.

  • Acne Treatment
  • Opioid
  • Therapy
  • Product Initiative
  • Syros Pharmaceuticals, Inc.

The net loss of the company was AUD## million in FY2018, compared to a net loss of AUD##. ## million in FY2017.

  • Acne Treatment
  • Dermatological Condition
  • Opioid
  • Pharmaceutical
  • Therapy

Patients enrolled will be randomized into one of three arms to receive a weight adjusted equivalent of ##. ## mg or ##. ## mg of palovarotene daily, or placebo.

  • Acne Treatment
  • Dermatological Condition
  • Opioid
  • Pharmaceutical
  • Therapy

Patients enrolled will be randomized into one of three arms to receive a weight adjusted equivalent of ##. ## mg or ##. ## mg of palovarotene daily, or placebo.

  • Acne Treatment
  • Opioid
  • United States
  • Product Initiative
  • Clementia Pharmaceuticals Inc.

The net loss of the company was AUD##. ## million in FY2017, compared to a net loss of AUD##. ## million in FY2016.

  • Acne Treatment
  • Opioid
  • Therapy
  • Product Initiative
  • Syros Pharmaceuticals, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Clinical Trial
  • Eating Disorder
  • Hormone
  • Neurology
  • Opioid

The net loss of the company was AUD##. ## million in FY2017, compared to a net loss of AUD##. ## million in FY2016.

  • Acne Treatment
  • Dermatological Condition
  • Leukemia
  • Opioid
  • Therapy
  • INSYS THERAPEUTICS INC, PHOENIX, AZ COMPANY OVERVIEW

THIS DRUG IS APPROVED BY THE FDA APPROVED FOR TWO INDICATIONS: ##) CHEMOTHERAPY--INDUCED NAUSEA AND VOMITING (CINV); AND ##) ANOREXIA ASSOCIATED WITH WEIGHT LOSS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME.

  • Acne Treatment
  • Opioid
  • Actavis plc
  • Bedrocan Canada Inc.
  • Medical Marijuana, Inc.

One of the first patients who enrolled in the program reported a weight loss of ## pounds after three months along with healthier lifestyle habits.

  • Healthcare
  • Opioid
  • Therapy
  • United States
  • Biocorrx Inc

Patients enrolled will be randomized into one of three arms to receive a weight adjusted equivalent of ##. ## mg or ##. ## mg of palovarotene daily, or placebo.

  • Acne Treatment
  • Opioid
  • Pharmaceutical
  • United States
  • Product Initiative
  • INDIVIOR PLC
  • INSYS THERAPEUTICS INC

The operating loss of the company was US$##. ## million in FY2018, compared to an operating loss of US$## million in FY2017.

  • Opioid
  • Therapy
  • United States
  • Company
  • Product Initiative
  • ICURE PHARMACEUTICAL INC
  • DRUG OVERDOSE - PIPELINE BY IQURE PHARMA INC, H2 2019

It also decreased catalepsy and weight gain induced by APDs.

  • Acne Treatment
  • Opioid
  • United States
  • Company Operations
  • Product Initiative
  • SUBSYS®

Anesthesia comprises of three main aspects, the pain relief or analgesia effect, loss of memory of the surgery, and the last one is the muscle relaxation to facilitate surgery and manipulation.

  • Opioid
  • North America
  • United States
  • World
  • Market Size
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Eating Disorder
  • Mental Health
  • Neurology
  • Opioid